3.58
Capsovision Inc Aktie (CV) Neueste Nachrichten
CapsoVision chief financial officer steps down; company begins search for successor - Investing.com
CapsoVision CFO Kevin Lundquist Resigns - MarketWatch
Capsovision says Kevin Lundquist steps down as CFOSEC filing - MarketScreener
CapsoVision CFO Kevin Lundquist Steps Down - TipRanks
Ingestible Sensors Market Set for Dynamic Growth with Key Players CapsoVision, Inc., BodyCAP, etectRx - openPR.com
Head to Head Comparison: CapsoVision (NASDAQ:CV) vs. ReShape Lifesciences (OTCMKTS:RSLSD) - Defense World
Smart Pills Market Worth US$1.30 Billion By 2030 With 11.2% CAGR - Barchart.com
Smart Pills Market worth US$1.30 billion by 2030 with 11.2% CAGR - openPR.com
FY2028 EPS Estimates for CapsoVision Lowered by Roth Capital - MarketBeat
Critical Analysis: CapsoVision (NASDAQ:CV) vs. ReShape Lifesciences (OTCMKTS:RSLSD) - Defense World
Insider Transactions Reported | CapsoVision(CV)saw insider trading activity on 8/22/2025 - AInvest
FY2028 EPS Estimates for CapsoVision Cut by Roth Capital - Defense World
CapsoVision (NASDAQ:CV) Issues Earnings Results - MarketBeat
CapsoVision 2025 Q2 Earnings Net Loss Narrows 12.2% - AInvest
CapsoVision Reports Second Quarter 2025 Financial Results - GlobeNewswire
CapsoVision Reports Revenue Growth and IPO Success - TipRanks
CapsoVision Revenue Jumps 17 Percent - AOL.com
Smart Pills Company Evaluation Report 2025 | Medtronic, Olympus, and CapsoVision Lead with Minimally Invasive and AI-Enhanced Medical Technologies - Yahoo Finance
CapsoVision (NASDAQ:CV) versus ReShape Lifesciences (OTCMKTS:RSLSD) Head to Head Comparison - Defense World
Reviewing ReShape Lifesciences (OTCMKTS:RSLSD) and CapsoVision (NASDAQ:CV) - Defense World
CapsoVision, Inc.'s Quiet Period Set To Expire on August 11th (NASDAQ:CV) - MarketBeat
CapsoVision, Inc.’s (NASDAQ:CV) Quiet Period Will End on August 11th - Defense World
Is capsovision scam - AInvest
Roth Capital Predicts CapsoVision's Q2 Earnings (NASDAQ:CV) - MarketBeat
CapsoVision (NASDAQ:CV) Raised to Strong-Buy at Roth Capital - MarketBeat
Understanding the risks associated with CapsoVision's stock - AInvest
CapsoVision to Release Second Quarter 2025 Financial Results on Thursday, August 14, 2025 - GlobeNewswire
Capsovision, Inc. shares fall 2.19% intraday as Kioxia Corporation announces new UFS 4.1 devices for automotive applications. - AInvest
Q2 Earnings Estimate for CapsoVision Issued By Roth Capital - Defense World
Roth Capital Upgrades CapsoVision (NASDAQ:CV) to Strong-Buy - Defense World
CapsoVision (NASDAQ:CV) Rating Increased to Strong-Buy at Roth Capital - Defense World
CapsoVision (NASDAQ:CV) Upgraded at Roth Capital - Defense World
CapsoVision (NASDAQ:CV) Upgraded by Roth Capital to Strong-Buy Rating - Defense World
CapsoVision (NASDAQ:CV) Raised to “Strong-Buy” at Roth Capital - Defense World
Capsovision, Inc. shares rise 3.45% intraday after Canon Inc. announces share buyback plan. - AInvest
CapsoVision is a buy, this analyst says - Cantech Letter
Capsovision, Inc. shares fall 1.15% premarket after Canon Inc. announced a buyback plan. - AInvest
CapsoVision (NASDAQ:CV) Earns Speculative Buy Rating from Analysts at Benchmark - MarketBeat
Benchmark Co. Initiates CapsoVision(CV.US) With Buy Rating, Announces Target Price $5 - 富途牛牛
CapsoVision: Benchmark initiates coverage with Speculative Buy rating, $5 price target. - AInvest
CapsoVision stock initiated with Speculative Buy rating at Benchmark By Investing.com - Investing.com Australia
Benchmark starts CapsoVision with a Speculative Buy as CapsoCam Plus takes share - TipRanks
CapsoVision initiated with a Buy at Roth Capital - TipRanks
CapsoVision stock initiated with Buy rating at Roth/MKM on GI imaging potential - Investing.com Nigeria
CapsoVision stock initiated with Speculative Buy rating at Benchmark - Investing.com
CapsoVision Completes $27.5 Million Nasdaq IPO - Global Legal Chronicle
CapsoVision enters development agreement with Canon and announces partial IPO overallotment exercise - Investing.com India
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):